Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 94

1.

Medical Malpractice Analysis in Radiation Oncology: a Decade of Results from a National Comparative Benchmarking System.

Royce TJ, Dwyer K, Yu-Moe CW, DeRoo C, Jacobson JO, Tishler RB.

Int J Radiat Oncol Biol Phys. 2018 Nov 12. pii: S0360-3016(18)33956-7. doi: 10.1016/j.ijrobp.2018.11.009. [Epub ahead of print]

PMID:
30439486
2.

Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.

Sher DJ, Tishler RB, Pham NL, Punglia RS.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):875-882. doi: 10.1016/j.ijrobp.2018.04.018. Epub 2018 Apr 12.

PMID:
29976499
3.

Funding Support and Principal Investigator Leadership of Oncology Clinical Trials Using Radiation Therapy.

Giacalone NJ, Milani N, Rawal B, Catalano PJ, Nguyen PL, Schoenfeld JD, Tishler RB, Margalit DN.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):34-43. doi: 10.1016/j.ijrobp.2018.05.037. Epub 2018 May 22.

PMID:
29970311
4.

Evaluating the PD-1 Axis and Immune Effector Cell Infiltration in Oropharyngeal Squamous Cell Carcinoma.

Schoenfeld JD, Gjini E, Rodig SJ, Tishler RB, Rawal B, Catalano PJ, Uppaluri R, Haddad RI, Hanna GJ, Chau NG, Rabinowits G, Lorch J, Jo VY, Krane JF, Goguen LA, Annino DJ, Abdelrahman S, Lipschitz M, Margalit DN.

Int J Radiat Oncol Biol Phys. 2018 Sep 1;102(1):137-145. doi: 10.1016/j.ijrobp.2018.05.002. Epub 2018 Jun 29.

PMID:
29960819
5.

Response to ASTRO consensus guideline for oropharyngeal cancer: In Regard to Walker et al.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EE, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2018 May - Jun;8(3):e185-e186. doi: 10.1016/j.prro.2017.08.002. Epub 2017 Aug 5. No abstract available.

PMID:
29724403
6.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H.

Oncologist. 2017 Nov;22(11):1413. doi: 10.1634/theoncologist.2016-0298erratum. No abstract available.

7.

Patient-oriented toxicity endpoints after head and neck reirradiation with intensity modulated radiation therapy.

Margalit DN, Schoenfeld JD, Rawal B, Haddad RI, Catalano PJ, Goguen LA, Chau NG, Rabinowits G, Lorch JH, Annino DJ, Tishler RB.

Oral Oncol. 2017 Oct;73:160-165. doi: 10.1016/j.oraloncology.2017.08.012. Epub 2017 Sep 8.

PMID:
28939070
8.

Comparative Analysis of MicroRNA Expression among Benign and Malignant Tongue Tissue and Plasma of Patients with Tongue Cancer.

Rabinowits G, Bowden M, Flores LM, Verselis S, Vergara V, Jo VY, Chau N, Lorch J, Hammerman PS, Thomas T, Goguen LA, Annino D, Schoenfeld JD, Margalit DN, Tishler RB, Haddad RI.

Front Oncol. 2017 Aug 29;7:191. doi: 10.3389/fonc.2017.00191. eCollection 2017.

9.

Prospective analysis of radiation oncology image and plan-driven peer review for head and neck cancer.

Zairis S, Margalit DN, Royce TJ, Powlis WD, Tishler RB, Schoenfeld JD.

Head Neck. 2017 Aug;39(8):1603-1608. doi: 10.1002/hed.24800. Epub 2017 May 17.

PMID:
28513902
10.

Radiation therapy for oropharyngeal squamous cell carcinoma: Executive summary of an ASTRO Evidence-Based Clinical Practice Guideline.

Sher DJ, Adelstein DJ, Bajaj GK, Brizel DM, Cohen EEW, Halthore A, Harrison LB, Lu C, Moeller BJ, Quon H, Rocco JW, Sturgis EM, Tishler RB, Trotti A, Waldron J, Eisbruch A.

Pract Radiat Oncol. 2017 Jul - Aug;7(4):246-253. doi: 10.1016/j.prro.2017.02.002. Epub 2017 Apr 17.

PMID:
28428019
11.

Salivary and serum HPV antibody levels before and after definitive treatment in patients with oropharyngeal squamous cell carcinoma.

Hanna GJ, Sridharan V, Margalit DN, La Follette SK, Chau NG, Rabinowits G, Lorch JH, Haddad RI, Tishler RB, Anderson KS, Schoenfeld JD.

Cancer Biomark. 2017;19(2):129-136. doi: 10.3233/CBM-160071.

PMID:
28387659
12.

The Use of Hyperbaric Oxygen for the Prevention and Management of Osteoradionecrosis of the Jaw: A Dana-Farber/Brigham and Women's Cancer Center Multidisciplinary Guideline.

Sultan A, Hanna GJ, Margalit DN, Chau N, Goguen LA, Marty FM, Rabinowits G, Schoenfeld JD, Sonis ST, Thomas T, Tishler RB, Treister NS, Villa A, Woo SB, Haddad R, Mawardi H.

Oncologist. 2017 Mar;22(3):343-350. doi: 10.1634/theoncologist.2016-0298. Epub 2017 Feb 16. Review. Erratum in: Oncologist. 2017 Nov;22(11):1413.

13.

A comparative study of standard intensity-modulated radiotherapy and RapidArc planning techniques for ipsilateral and bilateral head and neck irradiation.

Pursley J, Damato AL, Czerminska MA, Margalit DN, Sher DJ, Tishler RB.

Med Dosim. 2017 Spring;42(1):31-36. doi: 10.1016/j.meddos.2016.10.004. Epub 2016 Dec 2.

PMID:
27919621
14.

Highlights in Head and Neck Cancer.

Chau NG, Tishler RB, Haddad RI.

JAMA Oncol. 2017 Apr 1;3(4):441-442. doi: 10.1001/jamaoncol.2016.3648. No abstract available.

PMID:
27893016
15.

Merkel Cell Carcinoma: A Population Analysis on Survival.

Sridharan V, Muralidhar V, Margalit DN, Tishler RB, DeCaprio JA, Thakuria M, Rabinowits G, Schoenfeld JD.

J Natl Compr Canc Netw. 2016 Oct;14(10):1247-1257.

PMID:
27697979
16.

Patterns of failure after reirradiation with intensity-modulated radiation therapy and the competing risk of out-of-field recurrences.

Margalit DN, Rawal B, Catalano PJ, Haddad RI, Goguen LA, Annino DJ, Limaye SA, Lorch JH, Lavigne AW, Schoenfeld JD, Sher DJ, Tishler RB.

Oral Oncol. 2016 Oct;61:19-26. doi: 10.1016/j.oraloncology.2016.07.012. Epub 2016 Aug 6.

PMID:
27688100
17.

Acupuncture for Chemoradiation Therapy-Related Dysphagia in Head and Neck Cancer: A Pilot Randomized Sham-Controlled Trial.

Lu W, Wayne PM, Davis RB, Buring JE, Li H, Macklin EA, Lorch JH, Burke E, Haddad TC, Goguen LA, Rosenthal DS, Tishler RB, Posner MR, Haddad RI.

Oncologist. 2016 Dec;21(12):1522-1529. Epub 2016 Aug 10.

18.

Intensive treatment and survival outcomes in NUT midline carcinoma of the head and neck.

Chau NG, Hurwitz S, Mitchell CM, Aserlind A, Grunfeld N, Kaplan L, Hsi P, Bauer DE, Lathan CS, Rodriguez-Galindo C, Tishler RB, Haddad RI, Sallan SE, Bradner JE, French CA.

Cancer. 2016 Dec 1;122(23):3632-3640. doi: 10.1002/cncr.30242. Epub 2016 Aug 10.

19.

Definitive chemoradiation alters the immunologic landscape and immune checkpoints in head and neck cancer.

Sridharan V, Margalit DN, Lynch SA, Severgnini M, Zhou J, Chau NG, Rabinowits G, Lorch JH, Hammerman PS, Hodi FS, Haddad RI, Tishler RB, Schoenfeld JD.

Br J Cancer. 2016 Jul 12;115(2):252-60. doi: 10.1038/bjc.2016.166. Epub 2016 Jul 5.

20.

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients.

Sridharan V, Margalit DN, Lynch SA, Severgnini M, Hodi FS, Haddad RI, Tishler RB, Schoenfeld JD.

J Immunother Cancer. 2016 Jun 21;4:32. doi: 10.1186/s40425-016-0138-9. eCollection 2016.

21.

Population-based validation of the recursive partitioning analysis-based staging system for oropharyngeal cancer.

Keane FK, Chen YH, Tishler RB, Schoenfeld JD, Haddad RI, Goguen LA, Catalano P, Neville BA, Margalit DN.

Head Neck. 2016 Oct;38(10):1530-8. doi: 10.1002/hed.24470. Epub 2016 Apr 15.

PMID:
27080700
22.

Cost-Effectiveness Analysis of Chemoradiation Therapy Versus Transoral Robotic Surgery for Human Papillomavirus-Associated, Clinical N2 Oropharyngeal Cancer.

Sher DJ, Fidler MJ, Tishler RB, Stenson K, al-Khudari S.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):512-22. doi: 10.1016/j.ijrobp.2015.11.006. Epub 2015 Nov 10.

PMID:
26867880
23.

Synchronous squamous cell carcinoma and diffuse large B-cell lymphoma of the head and neck: the odd couple.

Raldow AC, Brown JG, Chau N, Davids MS, Margalit DN, Tishler RB, Ng A, Schoenfeld JD.

BJR Case Rep. 2016 Jan 19;2(1):20150271. doi: 10.1259/bjrcr.20150271. eCollection 2016.

24.

Incorporation of Next-Generation Sequencing into Routine Clinical Care to Direct Treatment of Head and Neck Squamous Cell Carcinoma.

Chau NG, Li YY, Jo VY, Rabinowits G, Lorch JH, Tishler RB, Margalit DN, Schoenfeld JD, Annino DJ, Goguen LA, Thomas T, Becker H, Haddad T, Krane JF, Lindeman NI, Shapiro GI, Haddad RI, Hammerman PS.

Clin Cancer Res. 2016 Jun 15;22(12):2939-49. doi: 10.1158/1078-0432.CCR-15-2314. Epub 2016 Jan 13.

25.

Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience.

Lorch JH, Hanna GJ, Posner MR, O'Neill A, Thotakura VL, Limaye SA, Rabinowits G, Sher DJ, Tishler RB, Haddad RI.

Head Neck. 2016 Apr;38 Suppl 1:E1618-24. doi: 10.1002/hed.24289. Epub 2015 Nov 28.

PMID:
26614576
26.

Radiation Oncology--New Approaches in Squamous Cell Cancer of the Head and Neck.

Margalit DN, Schoenfeld JD, Tishler RB.

Hematol Oncol Clin North Am. 2015 Dec;29(6):1093-106. doi: 10.1016/j.hoc.2015.07.008. Review.

PMID:
26568550
27.

Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus era.

Keane FK, Chen YH, Neville BA, Tishler RB, Schoenfeld JD, Catalano PJ, Margalit DN.

Cancer. 2015 Aug 1;121(15):2594-602. doi: 10.1002/cncr.29402. Epub 2015 Apr 14.

28.

Ensuring head and neck oncology patients receive recommended pretreatment dental evaluations.

Margalit DN, Losi SM, Tishler RB, Schoenfeld JD, Ann Fugazzotto J, Stephens J, Cebulski AL, Hammerstrand EL, Ma L, Lopes HM, Haddad RI, Treister NS, Frustino JL.

J Oncol Pract. 2015 Mar;11(2):151-4. doi: 10.1200/JOP.2014.000414. Epub 2015 Jan 27.

PMID:
25628388
29.

Increased clarity on the use of radiotherapy in the management of desmoplastic melanoma.

Tishler RB.

Cancer. 2014 May 1;120(9):1315-8. No abstract available.

PMID:
24877163
30.

Thyroid malignancies in survivors of Hodgkin lymphoma.

Michaelson EM, Chen YH, Silver B, Tishler RB, Marcus KJ, Stevenson MA, Ng AK.

Int J Radiat Oncol Biol Phys. 2014 Mar 1;88(3):636-41. doi: 10.1016/j.ijrobp.2013.11.237.

PMID:
24521679
31.

Success of endoscopic pharyngoesophageal dilation after head and neck cancer treatment.

Chapuy CI, Annino DJ, Tishler RB, Haddad RI, Snavely A, Goguen LA.

Laryngoscope. 2013 Dec;123(12):3066-73. doi: 10.1002/lary.24268. Epub 2013 Jul 8.

32.

Trastuzumab for the treatment of salivary duct carcinoma.

Limaye SA, Posner MR, Krane JF, Fonfria M, Lorch JH, Dillon DA, Shreenivas AV, Tishler RB, Haddad RI.

Oncologist. 2013;18(3):294-300. doi: 10.1634/theoncologist.2012-0369. Epub 2013 Feb 21.

33.

Treatment of oropharyngeal squamous cell carcinoma with IMRT: patterns of failure after concurrent chemoradiotherapy and sequential therapy.

Sher DJ, Thotakura V, Balboni TA, Norris CM, Haddad RI, Posner MR, Lorch J, Goguen LA, Annino DJ, Tishler RB.

Ann Oncol. 2012 Sep;23(9):2391-8. doi: 10.1093/annonc/mdr609. Epub 2012 Mar 16.

PMID:
22425872
34.

Acupuncture for dysphagia after chemoradiation in head and neck cancer: rationale and design of a randomized, sham-controlled trial.

Lu W, Wayne PM, Davis RB, Buring JE, Li H, Goguen LA, Rosenthal DS, Tishler RB, Posner MR, Haddad RI.

Contemp Clin Trials. 2012 Jul;33(4):700-11. doi: 10.1016/j.cct.2012.02.017. Epub 2012 Mar 2.

35.

Treatment of oral cavity squamous cell carcinoma with adjuvant or definitive intensity-modulated radiation therapy.

Sher DJ, Thotakura V, Balboni TA, Norris CM Jr, Haddad RI, Posner MR, Lorch J, Goguen LA, Annino DJ, Tishler RB.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e215-22. doi: 10.1016/j.ijrobp.2011.02.023. Epub 2011 Apr 29.

PMID:
21531515
36.

Swallowing function following postchemoradiotherapy neck dissection: review of findings and analysis of contributing factors.

Chapuy CI, Annino DJ, Snavely A, Li Y, Tishler RB, Norris CM, Haddad RI, Goguen LA.

Otolaryngol Head Neck Surg. 2011 Sep;145(3):428-34. doi: 10.1177/0194599811403075.

37.

Relationship between radiation treatment time and overall survival after induction chemotherapy for locally advanced head-and-neck carcinoma: a subset analysis of TAX 324.

Sher DJ, Posner MR, Tishler RB, Sarlis NJ, Haddad RI, Holupka EJ, Devlin PM.

Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):e813-8. doi: 10.1016/j.ijrobp.2010.12.005. Epub 2011 Feb 6.

PMID:
21300455
38.

Efficacy and toxicity of chemoradiotherapy using intensity-modulated radiotherapy for unknown primary of head and neck.

Sher DJ, Balboni TA, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, Annino D, Tishler RB.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1405-11. doi: 10.1016/j.ijrobp.2010.04.029. Epub 2010 Dec 20.

PMID:
21177045
39.

Salivary gland tumors treated with adjuvant intensity-modulated radiotherapy with or without concurrent chemotherapy.

Schoenfeld JD, Sher DJ, Norris CM Jr, Haddad RI, Posner MR, Balboni TA, Tishler RB.

Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):308-14. doi: 10.1016/j.ijrobp.2010.09.042. Epub 2010 Nov 13.

PMID:
21075557
40.

Utilizing computed tomography as a road map for designing selective and superselective neck dissection after chemoradiotherapy.

Goguen LA, Chapuy CI, Sher DJ, Israel DA, Blinder RA, Norris CM, Tishler RB, Haddad RI, Annino DJ.

Otolaryngol Head Neck Surg. 2010 Sep;143(3):367-74. doi: 10.1016/j.otohns.2010.04.020.

PMID:
20723773
41.

Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.

Sher DJ, Haddad RI, Norris CM Jr, Posner MR, Wirth LJ, Goguen LA, Annino D, Balboni T, Allen A, Tishler RB.

Cancer. 2010 Oct 15;116(20):4761-8. doi: 10.1002/cncr.25305.

42.

Combined antegrade and retrograde esophageal dilation for head and neck cancer-related complete esophageal stenosis.

Goguen LA, Norris CM, Jaklitsch MT, Sullivan CA, Posner MR, Haddad RI, Tishler RB, Burke E, Annino DJ Jr.

Laryngoscope. 2010 Feb;120(2):261-6. doi: 10.1002/lary.20727.

PMID:
19998421
43.

Head and neck carcinomas across the age spectrum: epidemiology, therapy, and late effects.

Marcus KJ, Tishler RB.

Semin Radiat Oncol. 2010 Jan;20(1):52-7. doi: 10.1016/j.semradonc.2009.09.004. Review.

PMID:
19959031
44.

Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck.

Wirth LJ, Allen AM, Posner MR, Haddad RI, Li Y, Clark JR, Busse PM, Chan AW, Goguen LA, Norris CM, Annino DJ, Tishler RB.

Ann Oncol. 2010 Feb;21(2):342-7. doi: 10.1093/annonc/mdp477. Epub 2009 Nov 5.

PMID:
19892746
45.

Cost-effectiveness of CT and PET-CT for determining the need for adjuvant neck dissection in locally advanced head and neck cancer.

Sher DJ, Tishler RB, Annino D, Punglia RS.

Ann Oncol. 2010 May;21(5):1072-7. doi: 10.1093/annonc/mdp405. Epub 2009 Oct 15.

46.

Phase I study of C-TPF in patients with locally advanced squamous cell carcinoma of the head and neck.

Haddad RI, Tishler RB, Norris C, Goguen L, Balboni TA, Costello R, Wirth L, Lorch J, Andreozzi B, Annino D, Posner MR.

J Clin Oncol. 2009 Sep 20;27(27):4448-53. doi: 10.1200/JCO.2009.22.1333. Epub 2009 Aug 24.

PMID:
19704061
47.

Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.

Haddad R, Sonis S, Posner M, Wirth L, Costello R, Braschayko P, Allen A, Mahadevan A, Flynn J, Burke E, Li Y, Tishler RB.

Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525.

48.

Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.

Salama JK, Haddad RI, Kies MS, Busse PM, Dong L, Brizel DM, Eisbruch A, Tishler RB, Trotti AM, Garden AS.

Int J Radiat Oncol Biol Phys. 2009 Nov 1;75(3):725-33. doi: 10.1016/j.ijrobp.2008.11.059. Epub 2009 Apr 11.

PMID:
19362781
49.

Effect of dental restorations and prostheses on radiotherapy dose distribution: a Monte Carlo study.

Chin DW, Treister N, Friedland B, Cormack RA, Tishler RB, Makrigiorgos GM, Court LE.

J Appl Clin Med Phys. 2009 Feb 3;10(1):2853.

50.

Sequential therapy for the locally advanced larynx and hypopharynx cancer subgroup in TAX 324: survival, surgery, and organ preservation.

Posner MR, Norris CM, Wirth LJ, Shin DM, Cullen KJ, Winquist EW, Blajman CR, Mickiewicz EA, Frenette GP, Plinar LF, Cohen RB, Steinbrenner LM, Freue JM, Gorbunova VA, Tjulandin SA, Raez LE, Adkins DR, Tishler RB, Roessner MR, Haddad RI; TAX 324 Study Group.

Ann Oncol. 2009 May;20(5):921-7. doi: 10.1093/annonc/mdn752. Epub 2009 Jan 29.

PMID:
19179556

Supplemental Content

Loading ...
Support Center